Cerba charms investors new to high yield arena
Cerba European Lab, the clinical pathology laboratory company, raised €230m on January 30 by tapping its 7% 2020 bond and issuing a new note, which even attracted investors new to the high yield market.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts